Emerald Advisers, LLC Jazz Pharmaceuticals PLC Transaction History

Emerald Advisers, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 28, 2020	SELL	$95.68 - $121.88 $344,160 - $438,402	-3,597 Closed	0 $0
Q1 2020 Apr 30, 2020	BUY	$87.74 - $152.74 $315,600 - $549,405	3,597 New	3,597 $359,000
Q1 2019 May 01, 2019	SELL	$121.81 - $142.95 $306,595 - $359,805	-2,517 Closed	0 $0
Q4 2018 Jan 30, 2019	SELL	$115.94 - $166.74 $785,493 - $1.13 Million	-6,775 Reduced 72.91%	2,517 $312,000
Q3 2018 Oct 31, 2018	SELL	$161.01 - $180.57 $50,879 - $57,060	-316 Reduced 3.29%	9,292 $1.56 Million

Q2 2018 Jul 31, 2018	SELL	$146.33 - $183.18 $40,094 - $50,191	-274 Reduced 2.77%	9,608 $1.66 Million
Q1 2018 Apr 26, 2018	BUY	$135.59 - $157.16 $92,065 - $106,711	679 Added 7.38%	9,882 $1.49 Million
Q4 2017 Feb 05, 2018	SELL	$131.06 - $150.39 $62,515 - $71,736	-477 Reduced 4.93%	9,203 $1.24 Million
Q3 2017 Oct 30, 2017	BUY	$142.62 - $155.6 $1.38 Million - $1.51 Million	9,680	9,680 $1.42 Million

574

61.9M

856K

178K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $8.84B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.